FONR FONAR CORP

BEARISH Impact: 6/10 8-K
Horizon weeks Filed May 12, 2026 Processed 28d 9h ago SEC 0001731122-26-000710
8-K Item 2.02: Earnings release
Latest settled — T+5d ⚠ clustered
FONR ▲ 0.00% at T+5d
SHORT call ✗ call lost 0.00% · α vs SPY -1.16% · entry $18.86 → $18.86
Next anchor: T+20d in 5h
Latest observation: T+15 -0.81% FF3 residual α
Entry anchored
May 12, 03:58 PM ET
via Databento tick
T+1d
0.00%
call 0.00% · α -0.00%
$18.86
settled 28d ago
T+5d
0.00%
call 0.00% · α -1.16%
$18.86
settled 22d ago
T+20d
call — · α —
in 5h
T+60d
call — · α —
in 8w

Price Chart

Loading chart...

Executive Summary

FONAR reported a weak fiscal Q3 2026 with revenue declining 3% YoY to $26.5M, operating income down 33% to $2.4M, and diluted EPS falling 35% to $0.24. Operating cash flow for the nine-month period dropped 51% to $3.4M. The company is in the process of a take-private merger at $19.00/share, with a shareholder vote scheduled for May 28, 2026, which caps the stock near the deal price and makes the weak operational results largely moot for trading purposes.

Actionable Insight

The stock trades near the $19.00 take-private offer price, so the weak earnings are unlikely to move the stock materially. The key catalyst is the May 28 shareholder vote on the merger. Monitor for any stockholder litigation or competing bids that could disrupt the deal. If the merger fails, the stock would re-rate sharply lower given deteriorating fundamentals.

Key Facts

  • Total Revenues-Net decreased 3% to $26.5M for Q3 FY2026 vs $27.2M a year ago
  • Income from Operations decreased 33% to $2.4M for Q3 FY2026 vs $3.7M a year ago
  • Net Income decreased 25% to $2.3M for Q3 FY2026 vs $3.1M a year ago
  • Diluted EPS decreased 35% to $0.24 for Q3 FY2026 vs $0.37 a year ago
  • Nine-month operating cash flow decreased 51% to $3.4M vs $7.0M a year ago
  • SG&A increased 5% to $8.4M for Q3 FY2026 vs $8.0M a year ago
  • Record quarterly scan volume of 55,660, up 1.8% YoY
  • Shareholder vote on take-private merger at $19.00/share scheduled for May 28, 2026
  • Share repurchase program remains suspended due to pending merger

Financial Impact

Revenue decline of $0.7M (-3%), operating income decline of $1.2M (-33%), EPS decline of $0.13 (-35%) vs prior year quarter

revenueepsoperating incomeoperating cash flow

Risk Factors

  • Take-private merger fails to close, exposing stock to weak operational performance
  • Continued revenue and earnings decline without deal floor
  • Operating cash flow deterioration limits internal investment capacity
  • SG&A growth outpacing revenue growth compressing margins further

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001731122-26-000710
Document: fonar_8-k.htm0001731122-26-000710
Document: 0001731122-26-000710-index-headers.html0001731122-26-000710
Document: 0001731122-26-000710-index.html0001731122-26-000710
Document: 0001731122-26-000710.txt0001731122-26-000710
8-K Data (Synthetic)0001731122-26-000710
5 reports for FONR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for FONR — sortable, filterable
Type Now
Jun 3, 2026
6d ago
8-K
NEUTRAL ★ 7/10
$19.09 awaiting T+5awaiting T+5
May 21, 2026
19d ago
DEFA14A
NEUTRAL ★ 3/10
$18.90 $19.11▲ +1.14%▼ −0.52%
May 21, 2026
19d ago
8-K
NEUTRAL ★ 3/10
$18.90 $19.11▲ +1.14%▼ −0.52%
May 12, 2026
28d ago
DEFA14A
BEARISH ★ 7/10
$18.86 $18.86· 0.00%▼ −1.16%
May 12, 2026
28d ago
8-K
BEARISH ★ 6/10
$18.86 $18.86· 0.00%▼ −1.16%
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access